Trial progress

The trial was awarded a 12 month extension and will now run until December 2017.

Our target number of 410 patients was reached in December 2016.  The majority of patients have now recieved their 12 month follow up, and the remainder of patients will have completed the trial by November 2017.

Once data collection is complete in November, we will be looking at the results, and the outcomes will be published and communicated to all patients who have taken part in the trial.

Edit this page